NCT04989959View on ClinicalTrials.gov

[18F]PT2385 PET/CT in Patients with Renal Cell Carcinoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

August 18, 2026

Study Completion Date

August 18, 2027

Conditions
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Interventions
DRUG

[18F]PT2385

\[18F\]PT2385 infusion

PROCEDURE

Positron Emission Tomography/Computed Tomography

PET/CT scan after \[18F\]PT2385 infusion

PROCEDURE

Biopsy

CT-guided tumor biopsy

Trial Locations (1)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

Orhan Kemal Oz

OTHER